Cundy TF - Search Results

1

Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis.

Grey AB, Cundy TF, Reid IR. Grey AB, et al. Among authors: cundy tf. Clin Endocrinol (Oxf). 1994 May;40(5):671-7. doi: 10.1111/j.1365-2265.1994.tb03020.x. Clin Endocrinol (Oxf). 1994. PMID: 8013147

2

Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception.

Cundy T, Cornish J, Roberts H, Reid IR. Cundy T, et al. Am J Obstet Gynecol. 2002 May;186(5):978-83. doi: 10.1067/mob.2002.122420. Am J Obstet Gynecol. 2002. PMID: 12015524

3

A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.

Cundy T, Ames R, Horne A, Clearwater J, Roberts H, Gamble G, Reid IR. Cundy T, et al. J Clin Endocrinol Metab. 2003 Jan;88(1):78-81. doi: 10.1210/jc.2002-020874. J Clin Endocrinol Metab. 2003. PMID: 12519833 Clinical Trial.

4

Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial.

Reid IR, Cundy T, Grey AB, Horne A, Clearwater J, Ames R, Orr-Walker BJ, Wu F, Evans MC, Gamble GD, King A. Reid IR, et al. J Clin Endocrinol Metab. 2007 Jul;92(7):2446-52. doi: 10.1210/jc.2006-2264. Epub 2007 Apr 17. J Clin Endocrinol Metab. 2007. PMID: 17440020 Clinical Trial.

5

Low-dose fluoride in postmenopausal women: a randomized controlled trial.

Grey A, Garg S, Dray M, Purvis L, Horne A, Callon K, Gamble G, Bolland M, Reid IR, Cundy T. Grey A, et al. J Clin Endocrinol Metab. 2013 Jun;98(6):2301-7. doi: 10.1210/jc.2012-4062. Epub 2013 Apr 3. J Clin Endocrinol Metab. 2013. PMID: 23553866 Clinical Trial.

6

Bone density in women receiving depot medroxyprogesterone acetate for contraception.

Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR. Cundy T, et al. BMJ. 1991 Jul 6;303(6793):13-6. doi: 10.1136/bmj.303.6793.13. BMJ. 1991. PMID: 1830502 Free PMC article.

7

Recovery of bone density in women who stop using medroxyprogesterone acetate.

Cundy T, Cornish J, Evans MC, Roberts H, Reid IR. Cundy T, et al. BMJ. 1994 Jan 22;308(6923):247-8. doi: 10.1136/bmj.308.6923.247. BMJ. 1994. PMID: 8111260 Free PMC article.

8

Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post-menopausal women.

Grey A, Cundy T, Evans M, Reid I. Grey A, et al. Clin Endocrinol (Oxf). 1996 Mar;44(3):293-6. doi: 10.1046/j.1365-2265.1996.667488.x. Clin Endocrinol (Oxf). 1996. PMID: 8729524

9

Short-term effects of high dose oral medroxyprogesterone acetate on bone density in premenopausal women.

Cundy T, Farquhar CM, Cornish J, Reid IR. Cundy T, et al. J Clin Endocrinol Metab. 1996 Mar;81(3):1014-7. doi: 10.1210/jcem.81.3.8772567. J Clin Endocrinol Metab. 1996. PMID: 8772567

10

Spinal bone density in women using depot medroxyprogesterone contraception.

Cundy T, Cornish J, Roberts H, Elder H, Reid IR. Cundy T, et al. Obstet Gynecol. 1998 Oct;92(4 Pt 1):569-73. doi: 10.1016/s0029-7844(98)00270-1. Obstet Gynecol. 1998. PMID: 9764630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters